This Government Contract opportunity from Department Of Health And Human Services was posted on July 6, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
Notice of Intent to Award a Sole Source Commercial Simplified Acquisition Procedures (SAP) Purchase Order for Supply Chain Monitoring – Infant Formula
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The Food and Drug Administration intends to award a sole source firm-fixed-price commercial service contract to Circana, LLC for supply chain monitoring of infant formula in the United States, leveraging its unique capability to provide critical data essential to maintaining the continuity of the FDA’s response to the infant formula shortage. This acquisition is conducted under simplified acquisition procedures as a commercial service, authorized under FAR Part 6.103-1 due to the absence of any other responsible source capable of delivering the required data, and no other firms have expressed interest in meeting the requirements. The contract will provide two specific commercial tools: CLIN 1 includes two user licenses for the Out of Stock Tracking Solution and CLIN 2 includes one user license for Liquid Data Go, both scheduled for delivery by July 30, 2026, with one-year validity periods. The acquisition is classified under NAICS code 541910 for Marketing Research and Public Opinion Polling with a total value of $22.5 million. The point of contact for inquiries and submissions is Haroon Gulzar at the FDA Office of Acquisition and Grant Services, with responses required by July 10, 2026, at 5:00 p.m. Eastern Time. The notice explicitly states this is not a competitive solicitation; however, any other firm seeking consideration must submit a capability statement demonstrating its ability to meet the requirements, and the government retains full discretion to determine whether to open the requirement to competition based on any such submissions. The place of performance is in Chicago, Illinois, while the contracting office is located in Rockville, Maryland.
General Info
Agency
NAICS
Place of Performance
Chicago, IL, USASet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Submission Closed
Organization & Contact Information
Full Description
The Food and Drug Administration (FDA) intends to award a Sole Source firm-fixed-price commercial service contract to Circana, LLC (Circana), 203 North LaSalle Street, Suite 1500, Chicago, IL, 60601, USA, for the Purchase of Supply Chain Monitoring – Infant Formula in accordance with the authority under FAR RFO Part 6.103-1 , Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements.
Circana is the only known source capable of obtain critical data needed to monitor the availability of infant formula products in the United States to support continuity of the FDA’s monitoring the infant formula supply chain - U.S. infant formula shortage initiative. No other sources have expressed an interest in writing in the proposed acquisition.
This acquisition is being conducted using simplified acquisition procedures in accordance with FAR RFO Part 12 for the acquisition of commercial products and commercial services.
The North American Industry Classification System (NAICS) code for the proposed acquisition is 541910 - Marketing Research and Public Opinion Polling $22.5.
Deliverables:
CLIN 1 - Out of Stock Tracking Solution (OOS) - 2 user licenses – Estimated Delivery Date 07/30/2026 (Valid 1 Year)
CLIN 2 - Liquid Data Go (LDG) - 1 user license - Estimated Delivery Date 07/30/2026 (Valid 1 Year)
Responses
Responses to this notice should be sent to Haroon Gulzar at haroon.gulzar@fda.hhs.gov no later than 5:00 pm (ET) on July 10, 2026. This notice is not a request for competitive quotes. Any other firms desiring consideration must fully identify their interest and capability of meeting the requirements by submitting a capability statement. Any response shall undergo review to determine if it can meet the requirements. A determination by the Government not to compete this proposed requirement based upon a response to this notice is solely within the discretion of the Government.
More opportunities from Department Of Health And Human Services → FDA Office Of Acq Grant Svcs
Same awarding agency
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS
